86 related articles for article (PubMed ID: 9750074)
21. Anti-apoptotic N-cadherin signaling and its prognostic implication in human hepatocellular carcinomas.
Gwak GY; Yoon JH; Yu SJ; Park SC; Jang JJ; Lee KB; Lee SH; Lee SM; Shin CS; Suh KS; Lee HS
Oncol Rep; 2006 May; 15(5):1117-23. PubMed ID: 16596172
[TBL] [Abstract][Full Text] [Related]
22. The clinical significance of soluble E-cadherin in nonsmall cell lung cancer.
Charalabopoulos K; Gogali A; Dalavaga Y; Daskalopoulos G; Vassiliou M; Bablekos G; Karakosta A; Constantopoulos S
Exp Oncol; 2006 Mar; 28(1):83-5. PubMed ID: 16614715
[TBL] [Abstract][Full Text] [Related]
23. Influence of age on soluble E-cadherin serum levels prevents its utility as a disease marker in gastric cancer patients.
Pedrazzani C; Caruso S; Corso G; Marrelli D; Neri A; Berardi A; Roviello F
Scand J Gastroenterol; 2008; 43(6):765-6. PubMed ID: 18569997
[No Abstract] [Full Text] [Related]
24. [Endoscopic diagnosis of colitic cancer and dysplasia].
Iwao Y; Matsuoka K; Ogata H; Hibi T
Nihon Rinsho; 2005 May; 63(5):738-9. PubMed ID: 15881163
[No Abstract] [Full Text] [Related]
25. E-cadherin and beta-catenin mRNA levels throughout colon cancer progression.
Truant SC; Gouyer VP; Leteurtre EA; Zerimech F; Huet GM; Pruvot FR
J Surg Res; 2008 Dec; 150(2):212-8. PubMed ID: 18316097
[TBL] [Abstract][Full Text] [Related]
26. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
27. Staging colonic and rectal cancer.
Stearns MW
Int Adv Surg Oncol; 1981; 4():189-208. PubMed ID: 7251173
[No Abstract] [Full Text] [Related]
28. [Association of galectin-3 and E-cadherin expressions with lymph node metastasis of colon cancer].
Wu ZH; Gan L
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1731-3. PubMed ID: 18024302
[TBL] [Abstract][Full Text] [Related]
29. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
[TBL] [Abstract][Full Text] [Related]
30. Staging for liver cancer.
Daniele B; Perrone F
Clin Liver Dis; 2005 May; 9(2):213-23, vi. PubMed ID: 15831269
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
32. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
33. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
Dabrowska B; Krasnodebski IW; Tadeusiak W
Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
Lee YC; Wu CT; Chen CS; Chang YL
Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
[TBL] [Abstract][Full Text] [Related]
35. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
36. [Correlation and significance of E-cadherin and N-cadherin expression in prostate cancer].
Huang X; Zhou LQ; Ai JK; Lu YQ; Bai Y; Zeng L; Zhang ZW; Guo YL
Ai Zheng; 2002 Nov; 21(11):1208-11. PubMed ID: 12526217
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
[TBL] [Abstract][Full Text] [Related]
38. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
[TBL] [Abstract][Full Text] [Related]
40. [Natural history of synchronous hepatic metastases from a non-treated colorectal cancer].
Giacchi R; Sebastiani M; Lungarotti F
J Chir (Paris); 1988; 125(6-7):419-23. PubMed ID: 3209636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
